ADAditxt, Inc. ADTX · OTC
$0.00 -33.33% (-$0.00)
- Market cap
- $598.8K
- Enterprise value
- $4.56M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 41.8x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -406.3%
- Gross margin
- 19.9%
- Net margin
- -362,386.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.93
- Free float
- 0.0%
About the company
Aditxt, Inc. (ADTX) is a biotechnology company specializing in the development of innovative therapeutic and diagnostic technologies in the fields of immunology and biomedicine. The company focuses on developing products that can enhance patients' immune systems and improve their health. Aditxt develops diagnostic tools that allow for precise monitoring of immune responses and patients' health status. With the growing emphasis on personalized medicine and advanced diagnostic technologies, Aditxt, Inc. has the potential for sustained growth. Aditxt, Inc. (ADTX) shares might be an interesting choice for investors seeking involvement in the biotechnology and innovative diagnostic therapies industry.
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey Busch
Employees
26
Headquarters
Mountain View
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number